Category: Prevention


Melanoma Research Alliance Announces $8.1 million in Research Awards

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 27 April 2021 In News, Prevention, Science, Treatment

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued on the cusp of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.

Read More


Summer Kramer: Aligning Passion with Purpose

19 April 2021 In Allies & Partnerships, Melanoma Stories, Prevention

Frustrated with her inability to find stylish UPF protective clothing after her own melanoma diagnosis, Summer Kramer founded her own company called SUMMERSKIN. Now, eight years later, she has aligned her passion with purpose through a new partnership with the Melanoma Research Alliance.

Read More


UV Exposure & Risk of Cutaneous Melanoma in Skin of Color

By Rachel Fischer, Ph.D., Associate Director, Scientific Program & Registry | 14 April 2021 In News, Prevention, Science

In JAMA Dermatology, a team led by Adewole S. Adamson, MD, from The University of Texas at Austin, investigates whether there is an association, specifically in People of Color, between UV exposure and melanoma. MRA breaks down what this research means and how it should impact your sun safety practices.

Read More


Estimating Melanoma Risk by Examining Skin’s Mutational Burden

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 10 February 2021 In Prevention, Science

 We’ve known for decades that most melanomas – formed from the color-producing cells in our skin called melanocytes – are predominantly caused by UV-radiation-induced damage from the sun or indoor tanning devices. This damage is cumulative but is often invisible.

Read More


Five Melanoma Research Highlights to Look Forward to in 2021

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment

At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.

Read More


Fueling a Revolution: Driving Research Forward

21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.

Read More


A Personal Journey, A Virtual Platform

23 June 2020 In Melanoma Stories, Prevention, Science

Meet Shirin Bajaj, a third-year resident at NYU’s School of Medicine and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Maintaining Momentum in Melanoma Research

8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment

The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.

Read More


Lighting up Melanoma (One Cell at a Time)

18 May 2020 In Allies & Partnerships, Prevention, Science, Treatment

Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Melanoma Research Advances – 2019 in Review

By Marc Hurlbert, PhD, MRA Chief Executive Officer | 27 January 2020 In Policy, Prevention, Science, Treatment

During 2019, melanoma research continued its rapid pace of advancement, with FDA approval of a new adjuvant therapy treatment option, several first-in-human clinical trials, and significant progress towards earlier intervention.

Read More


Login

×